Connecticut and Washington will not offer extensions
If a consumer begins the enrollment process by 11:59 on March 31, 2014, and experiences a delay because site traffic or technical issues, all but two states will allow an extension. Other 'hardship' extensions are possible for states using healthcare.gov, such as natural disasters, a death in the family or domestic violence.
Alabama 4/15
Alaska 4/15
Arizona 4/15
Arkansas 4/15
California 4/15
Colorado 4/15
Connecticut None
Delaware 4/15
District of Columbia 4/15
Florida 4/15
Georgia 4/15
Hawaii TBA
Idaho 4/15
Illinois 4/15
Indiana 4/15
Iowa 4/15
Kansas 4/15
Kentucky 4/15
Louisiana 4/15
Maine 4/15
Maryland TBA
Massachusetts 4/15
Michigan 4/15
Minnesota TBA
Mississippi 4/15
Missouri 4/15
Montana 4/15
Nebraska 4/15
Nevada 5/30
New Hampshire 4/15
New Jersey 4/15
New Mexico 4/15
New York TBA
North Carolina 4/15
North Dakota 4/15
Ohio 4/15
Oklahoma 4/15
*Oregon 4/30
Pennsylvania 4/15
Rhode Island TBA
South Carolina 4/15
South Dakota 4/15
Tennessee 4/15
Texas 4/15
Utah 4/15
Vermont 4/15
Virginia 4/15
Washington None
West Virginia 4/15
Wisconsin 4/15
Wyoming 4/15
* Regardless of initiation date, deadline extended due to site technical issues
Source: acasignups.net
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More